Mustang Bio, Inc. (MBIO): Net Income
-$1.92M
Year ended 2025-12-31
-$3.03M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.92M | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$15.75M | n/m | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$51.60M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$77.53M | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$66.37M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$60.02M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$46.39M | n/m | 2021-03-24, From 2019-01-01 |
| 2018-12-31 | -$30.66M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$31.29M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$12.65M | n/a | 2018-03-29, From 2016-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | -$1.92M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$16.59M | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$11.84M | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$26.17M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$9.63M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$11.23M | n/m |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | -$26.26M | n/m |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $6.90M | -8.0% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$43.10M | n/m |
Compare MBIO, LSTA, IBO, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗